Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials.

Walach H, Möllinger H, Sherr J, Schneider R.

J Psychopharmacol. 2008 Jul;22(5):543-52.

ABSTRACT: Authors conducted two parallel, blinded homeopathic pathogenetic trials to determine whether symptoms reported by healthy volunteers were significantly different for homeopathic remedies than for placebos.

Authors found significantly more remedy-specific symptoms in provers taking homeopathic remedies than in provers taking placebo.


A homoeopathic proving of Galphimia glauca.

Teut M, Dahler J, Schnegg C; Wilsede Study Group for Homoeopathic Provings.

Forsch Komplementmed. 2008 Aug;15(4):211-7.

ABSTRACT: Galphimia glauca was proved in a randomised, double-blind, placebo-controlled trial with a 1-week baseline, 4-week proving, and 2-week post-observational period. Authors’ results confirm the toxicological and clinical effects of Galphimia glauca compared to placebo, but the ICCH criteria for proving symptoms were not suitable to distinguish between specific and unspecific symptoms.